-
CAMERA2: Standard MRSA treatment does not outperform combination therapy
Standard treatment for Methicillin-resistant Staphylococcus aureus (MRSA) infection is not more efficacious than combination therapy, according to new research published in JAMA.
-
Trial shows using two drugs not better than one when treating MRSA blood infections
Researchers of methicillin-resistant Staphylococcus aureus (MRSA) blood infections say combination of two antibiotics was no better than one.
-
PhD Expression of Interest | Camera 2 Study
We are looking for EOI for an ID / microbiology fellow to conduct follow-on studies from CAMERA2 as part of a PhD.
-
Combination Therapy for MRSA Bloodstream Infections: Still a Question Mark
In an editorial by Thomas Holland, at Duke University School of Medicine, and Prof Joshua Davis, at Menzies highlighted the significance of the new study’s findings in the larger context.
-
Skin disease a 'national crisis'
NT News report on the HOT NORTH One Disease Skin Symposium attend by Australia's first Indigenous dermatologist Larrakia woman Dr Dana Slape
-
First Aboriginal Australian Dermatologist to Attend Skin Health Symposium in Darwin
This week Larrakia woman, Dr Dana Slape, Australia's first Aboriginal dermatologist, is back home to country to attend a Skin Health Symposium
-
The winner takes it all for S. aureus
The CAMERA2 study, executed in multiple countries addressing the question whether addition of a beta-lactam antibiotic (7 days) improves outcome in patients with MRSA bacteremia.
-
Contagion® to Report on the ECCMID Conference in Amsterdam
Steven Y. C. Tong, PhD, with the Menzies School of Health Research in Darwin, Australia, will speak about the results of the CAMERA2 trial on combination antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteremia.
-
Pain free golden staph treatment cleared for use in remote communities
A northern Australian research team has provided reassuring support for the continued use of an oral treatment option for patients with skin infections, finding that there has been inaccurate reporting of resistance to the recommended antibiotic.
-
‘Golden staph’ three species, not one
'Stories of Australian Science' magazine
-
Researchers discover a new silver species of Staphylococcus
Scientists from a pioneering Northern Territory-based research project have uncovered two new species of staphylococcus. One of the two has been officially registered as Staphylococcus argenteus, or more commonly Silver Staph.
-
Infectious diseases specialist awarded $75 000 to continue fight against super-bug.
The grant will provide vital funding to develop trials in the areas of Staphylococcus aureus (golden Staph) infections, bone and joint infections and skin infections.
-
NHMRC career fellowship: Dr Josh Davis
Menzies infectious diseases specialist, Dr Josh Davis was recently awarded a Career Development Fellowship as part of the National Health and Medical Research Council’s (NHMRC) yearly multi-million dollar funding round. Josh’s fellowship...
-
NHMRC project snapshot: Dr Josh Davis
Menzies infectious diseases specialist, Dr Josh Davis was recently awarded a competitive project grant as part of the National Health and Medical Research Council’s (NHMRC) yearly multi-million dollar funding round.
-
Pioneering skin sores research to improve health of children globally
A NT-based research project investigating alternative and more practical treatments for skin sores is set to benefit the millions of children worldwide who suffer from this infection.
-
2011 Fulbright Northern Territory Scholar
Menzies researcher Dr Steven Tong has been awarded a prestigious Fulbright Scholarship for his critical research into golden staph, a major cause of severe community and hospital acquired infections.